Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.

Agonists at the nicotinic acetylcholine alpha 7 receptor (nAChR α7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion fr...

Full description

Bibliographic Details
Main Authors: Michael R Weed, Joseph Polino, Laura Signor, Mark Bookbinder, Deborah Keavy, Yulia Benitex, Daniel G Morgan, Dalton King, John E Macor, Robert Zaczek, Richard Olson, Linda J Bristow
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5736175?pdf=render
_version_ 1818541044291076096
author Michael R Weed
Joseph Polino
Laura Signor
Mark Bookbinder
Deborah Keavy
Yulia Benitex
Daniel G Morgan
Dalton King
John E Macor
Robert Zaczek
Richard Olson
Linda J Bristow
author_facet Michael R Weed
Joseph Polino
Laura Signor
Mark Bookbinder
Deborah Keavy
Yulia Benitex
Daniel G Morgan
Dalton King
John E Macor
Robert Zaczek
Richard Olson
Linda J Bristow
author_sort Michael R Weed
collection DOAJ
description Agonists at the nicotinic acetylcholine alpha 7 receptor (nAChR α7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion from mild cognitive impairment to AD in humans and can also be performed by nonhuman primates. Reversal of scopolamine-induced impairment of vsPAL performance may represent a translational approach for the development of nAChR α7 agonists. The present study investigated the effect of treatment with the acetylcholinesterase inhibitor, donepezil, or three nAChR α7 agonists, BMS-933043, EVP-6124 and RG3487, on vsPAL performance in scopolamine-treated cynomolgus monkeys. Scopolamine administration impaired vsPAL performance accuracy in a dose- and difficulty- dependent manner. The impairment of eventual accuracy, a measure of visuo-spatial learning during the task, was significantly ameliorated by treatment with donepezil (0.3 mg/kg, i.m.), EVP-6124 (0.01 mg/kg, i.m.) or BMS-933043 (0.03, 0.1 and 0.3 mg/kg, i.m.). Both nAChR α7 agonists showed inverted-U shaped dose-effect relationships with EVP-6124 effective at a single dose only whereas BMS-933043 was effective across at least a 10 fold dose/exposure range. RG3487 was not efficacious in this paradigm at the dose range examined (0.03-1 mg/kg, i.m.). These results are the first demonstration that the nAChR α7 agonists, EVP-6124 and BMS-933043, can ameliorate scopolamine-induced cognitive deficits in nonhuman primates performing the vsPAL task.
first_indexed 2024-12-11T22:03:23Z
format Article
id doaj.art-7092e6186ae346de8340928c86171e4b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T22:03:23Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7092e6186ae346de8340928c86171e4b2022-12-22T00:49:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011212e018760910.1371/journal.pone.0187609Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.Michael R WeedJoseph PolinoLaura SignorMark BookbinderDeborah KeavyYulia BenitexDaniel G MorganDalton KingJohn E MacorRobert ZaczekRichard OlsonLinda J BristowAgonists at the nicotinic acetylcholine alpha 7 receptor (nAChR α7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion from mild cognitive impairment to AD in humans and can also be performed by nonhuman primates. Reversal of scopolamine-induced impairment of vsPAL performance may represent a translational approach for the development of nAChR α7 agonists. The present study investigated the effect of treatment with the acetylcholinesterase inhibitor, donepezil, or three nAChR α7 agonists, BMS-933043, EVP-6124 and RG3487, on vsPAL performance in scopolamine-treated cynomolgus monkeys. Scopolamine administration impaired vsPAL performance accuracy in a dose- and difficulty- dependent manner. The impairment of eventual accuracy, a measure of visuo-spatial learning during the task, was significantly ameliorated by treatment with donepezil (0.3 mg/kg, i.m.), EVP-6124 (0.01 mg/kg, i.m.) or BMS-933043 (0.03, 0.1 and 0.3 mg/kg, i.m.). Both nAChR α7 agonists showed inverted-U shaped dose-effect relationships with EVP-6124 effective at a single dose only whereas BMS-933043 was effective across at least a 10 fold dose/exposure range. RG3487 was not efficacious in this paradigm at the dose range examined (0.03-1 mg/kg, i.m.). These results are the first demonstration that the nAChR α7 agonists, EVP-6124 and BMS-933043, can ameliorate scopolamine-induced cognitive deficits in nonhuman primates performing the vsPAL task.http://europepmc.org/articles/PMC5736175?pdf=render
spellingShingle Michael R Weed
Joseph Polino
Laura Signor
Mark Bookbinder
Deborah Keavy
Yulia Benitex
Daniel G Morgan
Dalton King
John E Macor
Robert Zaczek
Richard Olson
Linda J Bristow
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
PLoS ONE
title Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
title_full Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
title_fullStr Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
title_full_unstemmed Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
title_short Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
title_sort nicotinic alpha 7 receptor agonists evp 6124 and bms 933043 attenuate scopolamine induced deficits in visuo spatial paired associates learning
url http://europepmc.org/articles/PMC5736175?pdf=render
work_keys_str_mv AT michaelrweed nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT josephpolino nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT laurasignor nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT markbookbinder nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT deborahkeavy nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT yuliabenitex nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT danielgmorgan nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT daltonking nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT johnemacor nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT robertzaczek nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT richardolson nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning
AT lindajbristow nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning